Drug Profile
Research programme: HIV fusion inhibitors - Frontier Biotechnologies
Alternative Names: Second generation HIV fusion inhibitors - Frontier Biotechnologies; Vaginal microbicide - Frontier BiotechnologiesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Frontier Biotechnologies
- Class
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in China
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in China (Vaginal)
- 23 Sep 2011 Preclinical trials in HIV infections in China (unspecified route)